Dr. Panagiotis Konstantinopoulos, MD, PhD
Claim this profileDana Farber Cancer Institute
Studies Endometrial Cancer
Studies Ovarian Cancer
12 reported clinical trials
20 drugs studied
Area of expertise
1Endometrial Cancer
Stage IV
POLE positive
PMS2 positive
2Ovarian Cancer
Stage IV
BRCA2 negative
BRCA1 negative
Affiliated Hospitals
Clinical Trials Panagiotis Konstantinopoulos, MD, PhD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Letrozole + Abemaciclib vs Pembrolizumab
for Endometrial Cancer
A standard treatment for endometrial cancer is chemotherapy and pembrolizumab together followed by pembrolizumab maintenance for two years. This treatment regimen has shown benefit in terms of delaying cancer progression in prior clinical trials, but the benefit of the pembrolizumab maintenance treatment and whether all participants need it is unclear. This research is being done on the maintenance portion of treatment to compare the efficacy between the combination of letrozole + abemaciclib and pembrolizumab alone following chemotherapy and pembrolizumab. The names of the study drugs involved in this study are: * Abemaciclib (a type of cyclin-dependent kinase (CDK) inhibitor) * Letrozole (a type of aromatase inhibitor) * Pembrolizumab (a type of monoclonal antibody)
Recruiting1 award Phase 2
More about Panagiotis Konstantinopoulos, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Panagiotis Konstantinopoulos, MD, PhD has experience with
- Abemaciclib
- Letrozole
- Pembrolizumab
- Avelumab
- Olaparib
- M1774
Breakdown of trials Panagiotis Konstantinopoulos, MD, PhD has run
Endometrial Cancer
Ovarian Cancer
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Panagiotis Konstantinopoulos, MD, PhD specialize in?
Panagiotis Konstantinopoulos, MD, PhD focuses on Endometrial Cancer and Ovarian Cancer. In particular, much of their work with Endometrial Cancer has involved Stage IV patients, or patients who are POLE positive.
Is Panagiotis Konstantinopoulos, MD, PhD currently recruiting for clinical trials?
Yes, Panagiotis Konstantinopoulos, MD, PhD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Panagiotis Konstantinopoulos, MD, PhD has studied deeply?
Yes, Panagiotis Konstantinopoulos, MD, PhD has studied treatments such as Abemaciclib, Letrozole, Pembrolizumab.
What is the best way to schedule an appointment with Panagiotis Konstantinopoulos, MD, PhD?
Apply for one of the trials that Panagiotis Konstantinopoulos, MD, PhD is conducting.
What is the office address of Panagiotis Konstantinopoulos, MD, PhD?
The office of Panagiotis Konstantinopoulos, MD, PhD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02115 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.